Page last updated: 2024-08-25

rosiglitazone and Hematologic Diseases

rosiglitazone has been researched along with Hematologic Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
McMorran, M; Vu, D	1

Other Studies

1 other study(ies) available for rosiglitazone and Hematologic Diseases

Article	Year
Rosiglitazone (Avandia): hepatic, cardiac and hematological reactions. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2001, Jul-10, Volume: 165, Issue:1 Topics: Aged; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Female; Hematologic Diseases; Humans; Hypoglycemic Agents; Liver Failure; Male; Middle Aged; Rosiglitazone; Thiazoles; Thiazolidinediones	2001

Article

Year

Rosiglitazone (Avandia): hepatic, cardiac and hematological reactions.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2001, Jul-10, Volume: 165, Issue:1

Topics: Aged; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Female; Hematologic Diseases; Humans; Hypoglycemic Agents; Liver Failure; Male; Middle Aged; Rosiglitazone; Thiazoles; Thiazolidinediones

2001